MG
Metagenomi, Inc. Common Stock
MGX · NASDAQ
$1.10 -1.79% (-$0.02)
1M -10.57%
Market Cap $42.5M
P/E Ratio -
Div. Yield -
ROE 63.65%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/B 0.38x
P/S 3.14x
EV/FFO N/A
Growth
82 /100
Growing Rev. growth 13.59%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 741.58%
Gross margin 74.29%
FCF margin 632.67%
Quality
1 /100
Poor ROA 53.81%
ROIC 65.88%
Asset turnover 0.08x
Debt
98 /100
Low Current ratio 4.50x
Debt/Equity 0.34x
Debt/Assets N/A
Stability
48 /100
Moderate EPS volatility 24.86%
Beta 0.68x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre MGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Irish
Employees
113
Headquarters
Emeryville
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report